take aim at chronic pain - zero limits chiropractic€¦ · erchonia is the global leader in low...
TRANSCRIPT
A New Weapon toEffectively Treat Pain Without
Harmful Side EffectsEveryday in the US, 40 Americans Die from Prescription Painkiller Abuse, the CDC Says
Overdoses of opioid prescription drugs now kill more people in the U.S. than do overdoses from heroin and cocaine combined—Source WebMD.
Take Aim at Chronic Pain
Stop the Pain Without Harmful
Side Effects
Discover Laser Therapyand Take Fewer Prescription
Drugs for Pain
www.erchonia.com888.242.0571 Toll Free
Non-InvasivePain FreeNo Side EffectsProven Efficacy
uuuu
US PAT 6,013,096; US PAT 6,746,473For additional US and International patents and patent pending
information go to www.erchonia.com
Offical Brand Specifications
Logo MixBrand element Mix
CMYK
86%69%51%46%
375570
CMYK
69%46%32%5%
92120143
CMYK
1%94%86%0%
2355353
CMYK
24%100%97%18%
1653136
RGB
RGB
RGB
RGB
Font-Family Sansation | Colors -
PANTONE7546 C
PANTONE5415 C
PANTONE2034 C
PANTONE7628 C
About the Manufacturer:Erchonia is the global leader in low level laser healthcare applications. For nearly two decades, Erchonia has been conducting research & development with the world’s leading physicians to advance the science of low level lasers. Prior to market introductions, all Erchonia lasers are proven to be safe and effective through level (1) independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, treat acne, treat the appearance of cellulite, treat onychomycosis and veterinary applications. For additional information, visit www. erchonia.com.
©2015-2016 Erchonia Corporation. All rights reserved. Pain Patient Brochure Rev 2 12/16
LASER RADIATIONDO NOT STARE INTO BEAM
CLASS 2 LASER
Complies with 21 CFR 1040,10 and 1040,11except for deviations pursuant to
Laser Notice No. 50, dated July 26, 2001
640nm <10mWIEC 60825-1:2007
HLS
LASER RADIATIONDO NOT STARE INTO BEAM
CLASS 2 LASER
Complies with 21 CFR 1040,10 and 1040,11except for deviations pursuant to
Laser Notice No. 50, dated July 26, 2001
640nm <10mWIEC 60825-1:2001
BST_3
SPINE
INFLAMMATIONCAUSING PAIN
LASER RADIATIONACTIVATES CELLS
LASE
R
REDUCEDINFLAMMATION
SPINE SPINE
Ask your
doctor about the benefits of low
level lasers and learn how the Erchonia® laser can work to treat pain...
The answers are simpler than you might think.
In the United States it is estimated that 56 million individuals suffer from some form of chronic pain annually. The prevalence of chronic pain accounts for the greatest number of work absenteeism than any other group of diseases, and the prevalence of chronic pain reports is estimated to increase. Often, people with acute or chronic pain (low back pain, a sore knee, or persistent neck stiffness) will quickly turn to over-the-counter pain medicine for relief; however, the FDA recently issued strict warnings regarding the misuse and overdosing of over-the-counter pain medications due to severe complications such as stomach ulcers, hearing disorders and liver failure. Further, a growing concern amongst physicians exists regarding the side-effects associated with prescription pain medication.
Prevalence of ChronicPain in the US
Chronic Neck PainPost-Operative PainShoulder PainHeel Pain Related to Plantar Fasciitis
uuuu
Now There is a New Treatment that Has Been Proven Safe and Effective by the FDA Low level lasers from Erchonia offer a new clinically proven treatment option that is safe , effective and cleared by the FDA for the treatment of:
How it WorksLow level laser therapy (LLLT) or cold laser, is a painless, sterile, non-invasive, drug-free modality that is used for a variety of conditions such as, acute and chronic pain, body-contouring, acne and appearance of cellulite.
Housed within the mitochondria, the cell energy manufacturer, are receptors capable of absorbing distinct parameters of light. Think of these receptors like any drug receptors. When we consume a prescription medication, the compound is absorbed by the body and it locates a particular receptor; based upon its molecular design, will bind to that receptor. Once the drug binds, a secondary reaction inside the cell takes place. A similar mechanism is observed when exposing the body to a particular color of light. During a laser treatment, the light will penetrate the skin and is absorbed by this receptor within the mitochondria. Receptor stimulation with light promotes energy production, biochemical reactions, protein and growth factor synthesis, cell growth and proliferation and enhanced bloodand oxygen flow. Nothing Heals Faster®
www.erchonia.com